These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Recognition, assessment and management of neuroleptic malignant syndrome. Khan M; Farver D S D J Med; 2000 Sep; 53(9):395-400. PubMed ID: 11016275 [TBL] [Abstract][Full Text] [Related]
28. Neuroleptic malignant syndrome and its controversies. Margetić B; Aukst-Margetić B Pharmacoepidemiol Drug Saf; 2010 May; 19(5):429-35. PubMed ID: 20306454 [TBL] [Abstract][Full Text] [Related]
29. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature]. Marelli A; Bodini P; Dizioli P; Chiodelli G; Guarneri M; Boldori L Minerva Med; 1996; 87(1-2):45-51. PubMed ID: 8610025 [TBL] [Abstract][Full Text] [Related]
30. [Neuroleptic malignant syndrome--a case report on diagnosis, differential diagnosis and therapy of a life threatening complication of treatment with neuroleptics]. Staud L; Pflug B Psychiatr Prax; 1992 Jul; 19(4):114-8. PubMed ID: 1354879 [TBL] [Abstract][Full Text] [Related]
31. [Malignant hyperthermia and neuroleptic malignant syndrome: report of 4 clinical cases]. Samuelian JC; Chabannes JM; Vedy P; Kozak-Reiss G Encephale; 1999; 25(3):222-5. PubMed ID: 10434147 [TBL] [Abstract][Full Text] [Related]
33. A hazardous side effect of neuroleptics: diagnosis and treatment. Epperly TD; McGlaughlin VG; Leo KU Geriatrics; 1990 Aug; 45(8):58-62. PubMed ID: 1974232 [TBL] [Abstract][Full Text] [Related]
34. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review]. Khaldi S; Kornreich C; Choubani Z; Gourevitch R Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460 [TBL] [Abstract][Full Text] [Related]
35. [Neuroleptic malignant syndrome: a rare long lasting case report]. Lemos J; Mós M; Monteiro A; Henriques P Acta Med Port; 2010; 23(6):1155-9. PubMed ID: 21627894 [TBL] [Abstract][Full Text] [Related]